165 related articles for article (PubMed ID: 25213993)
1. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
3. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671
[TBL] [Abstract][Full Text] [Related]
5. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
[TBL] [Abstract][Full Text] [Related]
6. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract][Full Text] [Related]
7. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
8. CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.
Kong X; Guan J; Ma W; Li Y; Xing B; Yang Y; Wang Y; Gao J; Wei J; Yao Y; Xu Z; Dou W; Lian W; Su C; Ren Z; Wang R
Medicine (Baltimore); 2016 Feb; 95(7):e2830. PubMed ID: 26886640
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L
Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964
[TBL] [Abstract][Full Text] [Related]
11. Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?
Kong X; Wang Y; Dai C; Ma W; Wang R
Mol Neurobiol; 2017 Mar; 54(2):1568-1576. PubMed ID: 27206428
[TBL] [Abstract][Full Text] [Related]
12. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
13. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
Qiu L; Xu Y; Xu H; Yu B
BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
[TBL] [Abstract][Full Text] [Related]
15. The role of the CXCR4 cell surface chemokine receptor in glioma biology.
Ehtesham M; Min E; Issar NM; Kasl RA; Khan IS; Thompson RC
J Neurooncol; 2013 Jun; 113(2):153-62. PubMed ID: 23494875
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Implications of Human Telomerase Reverse Transcriptase Expression in Grade and Prognosis of Gliomas: a Systematic Review and Meta-analysis.
Li J; Li H; Liu J; Feng B; Feng M; Lv B; Cheng S; Yang X
Mol Neurobiol; 2016 Jul; 53(5):2887-2893. PubMed ID: 25895660
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Wang J; Yang CL; Zou LL
Mol Clin Oncol; 2017 Nov; 7(5):885-890. PubMed ID: 29075491
[TBL] [Abstract][Full Text] [Related]
18. Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma?
Arzoglou V; Tsitlakidis A; Foroglou N; Polyzoidis K; Makri S; Patsalas I
Br J Neurosurg; 2018 Dec; 32(6):614-618. PubMed ID: 30282472
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of CXCR4 in ovarian cancer: a meta-analysis.
Liu CF; Liu SY; Min XY; Ji YY; Wang N; Liu D; Ma N; Li ZF; Li K
PLoS One; 2014; 9(3):e92629. PubMed ID: 24658065
[TBL] [Abstract][Full Text] [Related]
20. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis.
Han M; Lv S; Zhang Y; Yi R; Huang B; Fu H; Bian R; Li X
Tumour Biol; 2014 May; 35(5):4589-97. PubMed ID: 24464926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
